HD Biosciences, Inc. (San Diego), a WuXi AppTec Company, is expanding its in vivo Pharmacology Division. We’re seeking a highly motivated Research Associate II to join the team.

• Assisting and performing efficacy and PK-PD studies and developing new in vivo/ ex vivo assays and models with minimum supervision, as needed
• Help to design, optimize and execute of pharmacology experiments for compound screening, compound mode of action and efficacy in mechanistic and disease models, e.g. syngeneic and xenograft tumor model, acute and chronic autoimmune/inflammatory conditions, and analyses and reporting of experiments or implantation, blood/tissue collection, etc.
• Assist with and perform other experiments as required
• Working with the team to perform assay development, optimization, and validation projects
• Following SOPs to perform compound receiving, registration, and management
• Help to manage lab coordination

• 1-3 years of experience in Biology related field
• Associates degree required or Bachelors and above preferred with 1-3 year’s experience in Biology related field
• Minimal experience in handling rodents/ mice in in vivo pharmacology studies
• Have experience in troubleshooting experiments and performing data analysis.
• Experience in cell culture, and cell manipulation is a plus
• Detail-oriented with excellent communication skills; able to work in a team-oriented environment.
• Effectively collaborate across cross functional teams, with excellent organizational and record-keeping skills

Knowledge / Skills / Abilities:

• Proficient in Oral & Written communication skills
• Need to be able to read, write and understand English
• Proficient in Microsoft (Excel, Word, Outlook)

Anticipated base pay range: $21.67 to $28.06

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.